Inaktiver Wert

Andere Sprachen Auris Medical Holding AG Nasdaq

Aktien

CH0408330303

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors	16.05.
Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation	01.05.
Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal	24.04.
Transcript : Altamira Therapeutics Ltd., 2023 Earnings Call, Apr 10, 2024	10.04.
Altamira Therapeutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10.04.
Sector Update: Health Care Stocks Decline Late Afternoon	25.03.
Top Midday Gainers	25.03.
Sector Update: Health Care Stocks Softer in Afternoon Trading	25.03.
Altamira, Univercells Partner to Test mRNA Vaccine Delivery; Shares Surge	25.03.
Altamira Therapeutics Ltd. Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines	25.03.
Altamira Therapeutics? Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal	07.02.
Altamira Files Second Provisional Patent Application in Cancer Treatment; Shares Rise	24.01.
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment	24.01.
Altamira Therapeutics Back in Compliance with Nasdaq Minimum Bid Price Rules	29.12.
Transcript : Altamira Therapeutics Ltd. - Special Call	11.12.
Altamira Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders Equity Requirement	29.11.
An unknown private equity investor acquired 51% stake in Altamira Medica AG from Altamira Therapeutics Ltd..	21.11.
Sector Update: Health Care Stocks Slipping Late Afternoon	17.11.
Top Midday Gainers	17.11.
Altamira Therapeutics to Sell 51% of Bentrio Maker for $2.3 Million	17.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Auris Medical Holding AG Nasdaq

Aktien

CH0408330303

Andere Sprachen

Filter